Evaluation of glycomic profiling as a diagnostic biomarker for epithelial ovarian cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 23, Issue 4, 2014, Pages 611-621

  Kim, Kyoungmi ^a   Ruhaak, L Renee ^a   Nguyen, Uyen Thao ^a   Taylor, Sandra L ^a   Dimapasoc, Lauren ^a   Williams, Cynthia ^a   Stroble, Carol ^a,b   Ozcan, Sureyya ^a   Miyamoto, Suzanne ^b   Lebrilla, Carlito B ^a   Leiserowitz, Gary S ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCAN DERIVATIVE; TUMOR MARKER;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER DIAGNOSIS; CARBOHYDRATE ANALYSIS; CASE CONTROL STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GLYCOBIOLOGY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MASS SPECTROMETER; OVARY CARCINOMA; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TIME OF FLIGHT MASS SPECTROMETRY; BLOOD; COHORT ANALYSIS; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROCEDURES;

CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GLYCOMICS; HUMANS; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84898718746     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-13-1073     Document Type: Article

References (25)

1. Zgheib NB, Xiong Y, Marchion DC, Bicaku E, Chon HS, Stickles XB, et al. The O-glycan pathway is associated with in vitro sensitivity to gemcitabine and overall survival from ovarian cancer. Int J Oncol 2012;41:179-88.
2. Moore RG, Jabre-Raughley M, Brown AK, Robison KM, Miller MC, Allard WJ, et al. Comparison of a novel multiple marker assay versus the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass. Am J Obstet Gynecol 2010;203:228.
3. Ruhaak LR, Miyamoto S, Lebrilla CB. Developments in the identification of glycan biomarkers for the detection of cancer. Mol Cell Proteomics 2013;12:846-55.
4. Mechref Y, Hu Y, Garcia A, Hussein A. Identifying cancer biomarkers by mass spectrometry-based glycomics. Electrophoresis 2012;33:1755-67.
5. An HJ, Lebrilla CB. A glycomics approach to the discovery of potential cancer biomarkers. Methods Mol Biol 2010;600:199-213.
6. Hua S, An HJ. Glycoscience aids in biomarker discovery. BMB Rep 2012;45:323-30.
7. Alley WR Jr, Vasseur JA, Goetz JA, Svoboda M, Mann BF, Matei DE, et al. N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients. J Proteome Res 2012;11:2282-300.
8. Kronewitter SR, De Leoz ML, Strum JS, An HJ, Dimapasoc LM, Guerrero A, et al. The glycolyzer: automated glycan annotation software for high performance mass spectrometry and its application to ovarian cancer glycan biomarker discovery. Proteomics 2012;12:2523-38.
9. Leiserowitz GS, Lebrilla C, Miyamoto S, An HJ, Duong H, Kirmiz C, et al. Glycomics analysis of serum: a potential new biomarker for ovarian cancer? Int J Gynecol Cancer 2008;18:470-5. (Pubitemid 351668296)
10. Saldova R, Royle L, Radcliffe CM, Abd Hamid UM, Evans R, Arnold JN, et al. Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Glycobiology 2007;17:1344-56. (Pubitemid 350131311)
11. Saldova R, Wormald MR, Dwek RA, Rudd PM. Glycosylation changes on serum glycoproteins in ovarian cancer may contribute to disease pathogenesis. Dis Markers 2008;25:219-32.
12. Kronewitter SR, de Leoz ML, Peacock KS, McBride KR, An HJ, Miyamoto S, et al. Human serum processing and analysis methods for rapid and reproducible N-glycan mass profiling. J Proteome Res 2010;9:4952-9.
13. Hua S, An HJ, Ozcan S, Ro GS, Soares S, DeVere-White R, et al. Comprehensive native glycan profiling with isomer separation and quantitation for the discovery of cancer biomarkers. Analyst 2011;136:3663-71.
14. Kronewitter SR, An HJ, de Leoz ML, Lebrilla CB, Miyamoto S, Leiserowitz GS. The development of retrosynthetic glycan libraries to profile and classify the human serum N-linked glycome. Proteomics 2009;9:2986-94.
15. van den Berg RA, Hoefsloot HC, Westerhuis JA, Smilde AK, van der Werf MJ. Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genomics 2006;7:142.
16. Taylor SL, Kim K. A jackknife and voting classifier approach to feature selection and classification. Cancer Inform 2011;10:133-47.
17. McShane LM, Cavenagh MM, Lively TG, Eberhard DA, Bigbee WL, Williams PM, et al. Criteria for the use of omics-based predictors in clinical trials. Nature 2013;502:317-20.
18. Packer NH, von der Lieth CW, Aoki-Kinoshita KF, Lebrilla CB, Paulson JC, Raman R, et al. Frontiers in glycomics: bioinformatics and biomarkers in disease. Proteomics 2008;8:8-20.
19. Hua S, Williams CC, Dimapasoc LM, Ro GS, Ozcan S, Miyamoto S, et al. Isomer-speci fic chromatographic profiling yields highly sensitive and specific potential N-glycan biomarkers for epithelial ovarian cancer. J Chromatogr A 2013;1279:58-67.
20. Imre T, Kremmer T, Heberger K, Molnar-Szollosi E, Ludanyi K, Pocsfalvi G, et al. Mass spectrometric and linear discriminant analysis of N-glycans of human serum alpha-1-acid glycoprotein in cancer patients and healthy individuals. J Proteomics 2008;71:186-97. (Pubitemid 351927284)
21. Kim YG, Jeong HJ, Jang KS, Yang YH, Song YS, Chung J, et al. Rapid and high-throughput analysis of N-glycans from ovarian cancer serum using a 96-well plate platform. Anal Biochem 2009;391:151-3.
22. Kornfeld R, Kornfeld S. Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem 1985;54:631-64. (Pubitemid 15073660)
23. Aldredge D, An HJ, Tang N, Waddell K, Lebrilla CB. Annotation of a serum N-glycan library for rapid identification of structures. J Proteome Res 2012;11:1958-68.
24. Parekh RB, Roitt IM, Isenberg DA, Dwek RA, Ansell BM, Rademacher TW. Galactosylation of IgG associated oligosaccharides: reduction in patients with adult and juvenile onset rheumatoid arthritis and relation to disease activity. Lancet 1988;1:966-9.
25. Huhn C, Selman MH, Ruhaak LR, Deelder AM, Wuhrer M. IgG glycosylation analysis. Proteomics 2009;9:882-913.